Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
Viralex is an immunomodulatory agent with broad-spectrum antiviral properties. It enhances both innate & adaptive immunity and strengthens the body's defence response to viral infections
Brinton Pharmaceuticals enters exclusive sales and distribution rights of Scholl foot care products including Krack cream
The accelerated growth of Medix Biochemica will establish its status as the ultimate IVD raw materials supplier
This has further strengthened its manufacturing presence in the United States of America
Serina has over 17 years of experience in the biopharmaceutical industry
Achieving ML 4 brings Singapore closer to becoming a WHO listed authority, a new scheme that will be operational later this year and will list the world’s regulators of reference
Under the terms of the agreement, the upfront payment from Alexion to Neurimmune is US $ 30m
Clinical trial supply company strengthens its presence in the European Union
The products are based on a combination of mushrooms and cannabinoids that have achieved a strong therapeutic effect using low concentrations of THC. The treatment is expected to be launched in Israel, US and UK in H2 2022
Subscribe To Our Newsletter & Stay Updated
